Synthetic Biologics (SYN)

Synthetic Biologics (NYSE Amex: SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension (PAH), relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis (ALS).

AT A GLANCE | COMPANY NEWS | COMPANY WEBSITE| SEC FILINGS


Comments are closed.